WO2001040472A3 - Antigènes dérivés de streptococcus pneumoniae - Google Patents

Antigènes dérivés de streptococcus pneumoniae Download PDF

Info

Publication number
WO2001040472A3
WO2001040472A3 PCT/GB2000/004602 GB0004602W WO0140472A3 WO 2001040472 A3 WO2001040472 A3 WO 2001040472A3 GB 0004602 W GB0004602 W GB 0004602W WO 0140472 A3 WO0140472 A3 WO 0140472A3
Authority
WO
WIPO (PCT)
Prior art keywords
streptococcus pneumoniae
pneumoniae antigens
antigenic
antigens
protein
Prior art date
Application number
PCT/GB2000/004602
Other languages
English (en)
Other versions
WO2001040472A2 (fr
Inventor
Alan William Cripps
Jennelle Maree Kyd
Maha Jomaa
Original Assignee
Cortecs Om Pty Ltd
Chapman Paul William
Alan William Cripps
Jennelle Maree Kyd
Maha Jomaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Om Pty Ltd, Chapman Paul William, Alan William Cripps, Jennelle Maree Kyd, Maha Jomaa filed Critical Cortecs Om Pty Ltd
Priority to CA002392895A priority Critical patent/CA2392895A1/fr
Priority to AU15405/01A priority patent/AU1540501A/en
Priority to JP2001542537A priority patent/JP2003515341A/ja
Priority to EP00977771A priority patent/EP1240329A2/fr
Publication of WO2001040472A2 publication Critical patent/WO2001040472A2/fr
Publication of WO2001040472A3 publication Critical patent/WO2001040472A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention se rapporte à une protéine antigénique dérivée de Streptococcus pneumoniae. Cette protéine antigénique s'avère utile s'agissant de la préparation de vaccins et du diagnostic de l'infection par Streptococcus pneumoniae.
PCT/GB2000/004602 1999-12-03 2000-12-01 Antigènes dérivés de streptococcus pneumoniae WO2001040472A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002392895A CA2392895A1 (fr) 1999-12-03 2000-12-01 Antigenes derives de streptococcus pneumoniae
AU15405/01A AU1540501A (en) 1999-12-03 2000-12-01 Streptococcus pneumoniae antigens
JP2001542537A JP2003515341A (ja) 1999-12-03 2000-12-01 ストレプトコッカス・ニューモニエ抗原
EP00977771A EP1240329A2 (fr) 1999-12-03 2000-12-01 ANTIG NES D RIV S DE i STREPTOCOCCUS PNEUMONIAE /i

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9928678.3 1999-12-03
GBGB9928678.3A GB9928678D0 (en) 1999-12-03 1999-12-03 Streptococcus pneumoniae antigens

Publications (2)

Publication Number Publication Date
WO2001040472A2 WO2001040472A2 (fr) 2001-06-07
WO2001040472A3 true WO2001040472A3 (fr) 2002-03-14

Family

ID=10865707

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/004602 WO2001040472A2 (fr) 1999-12-03 2000-12-01 Antigènes dérivés de streptococcus pneumoniae

Country Status (6)

Country Link
EP (1) EP1240329A2 (fr)
JP (1) JP2003515341A (fr)
AU (1) AU1540501A (fr)
CA (1) CA2392895A1 (fr)
GB (1) GB9928678D0 (fr)
WO (1) WO2001040472A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2261241A1 (fr) 2001-04-16 2010-12-15 Wyeth Holdings Corporation Cadres de lecture ouverts de streptococcus pneumoniae codant pour des antigenes polypeptidiques, et leurs utilisations
WO2011112906A2 (fr) 2010-03-12 2011-09-15 Children's Medical Center Corporation Nouveaux immunogènes et procédés pour la découverte et le dépistage de ceux-ci
ES2959258T3 (es) 2013-02-07 2024-02-22 Childrens Medical Center Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas
BR112021004193A2 (pt) 2018-09-12 2021-05-25 Affinivax, Inc. vacinas pneumocócicas multivalentes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014712A1 (fr) * 1993-11-24 1995-06-01 Research Corporation Technologies, Inc. ANTIGENES DE LIAISON DE L'HEMINE/HEMOGLOBINE DU $i(STREPTOCOCCUS PNEUMONIAE)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014712A1 (fr) * 1993-11-24 1995-06-01 Research Corporation Technologies, Inc. ANTIGENES DE LIAISON DE L'HEMINE/HEMOGLOBINE DU $i(STREPTOCOCCUS PNEUMONIAE)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THARPE, J.A. & RUSSELL, H.: "Purification and Seroreactivity of Pneumococcal Surface Adhesin A (PsaA)", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, vol. 3, no. 2, March 1996 (1996-03-01), pages 227 - 229, XP002109329 *

Also Published As

Publication number Publication date
JP2003515341A (ja) 2003-05-07
WO2001040472A2 (fr) 2001-06-07
AU1540501A (en) 2001-06-12
GB9928678D0 (en) 2000-02-02
CA2392895A1 (fr) 2001-06-07
EP1240329A2 (fr) 2002-09-18

Similar Documents

Publication Publication Date Title
WO2000056359A3 (fr) Vaccin
WO2000039299A3 (fr) Antigenes de streptococcus
WO2001098334A3 (fr) Antigenes de streptocoque
WO1999042588A3 (fr) Antigenes du streptocoque du groupe b
EP1731166A3 (fr) Protéines et vaccins de streptococcus pneumoniae
CA2198251A1 (fr) Conjugues immunogenes de polysaccharide-proteines utilises comme vaccins pour l'immunisation contre les infections a pneumocoques
WO2002072012A3 (fr) Nouvel adjuvant de vaccin proteosome-liposaccharide
AU6236396A (en) Omp26 antigen from haemophilus influenzae
WO2000062801A3 (fr) Nouvelles compositions
WO2003065973A8 (fr) Compositions de vaccins multivalents a base de streptocoques et procedes d'utilisation
WO2002034773A3 (fr) Genes streptococciques
WO2001081380A3 (fr) Proteine pneumococcique immunogenique et ses compositions de vaccins
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
WO2000058475A3 (fr) Proteines
WO2002034287A3 (fr) Nouvelles formulations de vaccin therapeutique
WO2001040472A3 (fr) Antigènes dérivés de streptococcus pneumoniae
CA2273922A1 (fr) Nouvelles compositions a base de saponine et leurs utilisations
EP1574579A3 (fr) Protéines de membranes externes, leurs gènes, et leur utilisation
WO2002004497A3 (fr) Peptides a antigenes multiples assurant l'immunite contre streptococcus pneumoniae
WO2005012339A3 (fr) Proteine immunogene et ses utilisations
EP1020516A3 (fr) Antigenes vaccinaux de Leptospira pour la prevention de la leptospirose
WO1999061909A3 (fr) Methodes et compositions de detection du virus de l'herpes humain
EP1950302A3 (fr) Nouveaux antigènes de streptocoque
AU4892199A (en) Serological diagnosis of protostrongylidae infections and identification of unique antigens
WO2002072622A3 (fr) Invention

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2392895

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 542537

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 008174032

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2000977771

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000977771

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000977771

Country of ref document: EP